Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Statement

6 Dec 2012 07:00

RNS Number : 8200S
PZ CUSSONS PLC
06 December 2012
 



6 December 2012

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2012.

 

First half trading

 

The overall performance of the Group for the first half of the year has been in line with management expectations. Whilst revenue has been broadly flat, mainly as a result of difficult trading conditions in Nigeria, profits have increased by approximately 10% versus the comparative period, driven in particular by an improvement in the profitability of the Australian business and a robust performance in the UK.

 

The financial position of the Group is strong with cash generation during the period also in line with expectations.

 

Trading - Update

 

Europe

 

In the UK washing and bathing division, the core brands of Imperial Leather, Carex and Original Source have performed well with an increase in profitability versus the prior period despite continued high levels of promotional activity in the trade. Significant investment was made during the period in the launch of Cussons Mum & Me, the new range of products for mother and baby, which achieved full UK distribution by the end of July. An extensive media campaign has been underway since August and the brand has been very positively received by consumers with encouraging early rates of sale.

 

Profitability in the beauty division is also ahead of the prior period. Whilst St Tropez was adversely affected by the poor summer, Sanctuary has performed particularly well benefiting from the launch of the new Active reverse skin care range with ballet star Darcey Bussell as brand ambassador. The Fudge hair care brand, acquired earlier in the year, has also performed well with a new Fudge.com e-commerce site launched towards the end of the period.

 

Performance in Poland has been robust with revenue and profit ahead of the prior period.

 

Revenue and profitability in Greece are lower as a result of the domestic economic situation.

 

Asia

 

Whilst trading conditions in Australia remain challenging, the measures taken to improve the performance of the business have now been successfully implemented. The production facility has been closed as part of a move to a variable cost model and the business returned to profitability in the period.

 

Continued positive momentum in Indonesia has delivered another period of revenue and profit growth largely from the market leading Cussons Baby range.

 

Trading in the smaller territories of Thailand and the Middle East has been in line with expectations.

 

Africa

 

In Nigeria, sales rates during the period have been affected by social unrest in the north of the country, flooding in a large number of states, and the more general impact on consumer disposable income as a result of the removal of part of the fuel subsidy earlier in the year. As a result, revenue is slightly lower than the prior period although margins in home and personal care are improving as a result of lower raw material costs and margin improvement projects.

 

Construction of the palm oil refinery with Wilmar in Nigeria is almost complete with commissioning of the facility due to commence this month. Sales of consumer products under a new brand are expected to begin before the end of the financial year.

 

Performance in the smaller territories of Ghana and Kenya has been in line with expectations.

 

Full year outlook

 

Trading conditions in most markets remain challenging with continued pressures on consumer disposable income. The situation in the Group's important Nigerian market continues to be fragile although the longer term opportunity remains exciting.

 

The Group's focus remains on new product development and further margin improvement. Raw material cost trends are expected to be favourable this year and the benefits of the supply chain optimisation project are also beginning to be seen.

 

The Board remains confident of a return to profitable growth in the current financial year.

 

Interim Announcement

 

Interim results for the half year to 30 November 2012 will be announced on Tuesday 29th January 2013.

 

An analysts' presentation will be given at 9:30am on that day at the new offices of Panmure Gordon, One New Change, London EC4M 9AF.

 

- ENDS -

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1236

Brandon Leigh - Finance Director

 

MHP Communications Tel: 020 3128 8100

John Olsen / James White / Nick Hayns

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVRSRUOAURAA
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.